Stay updated on SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial
Sign up to get notified when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.

Latest updates to the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior government funding/operating status notice (v3.4.1). These changes are site-wide maintenance updates and do not affect the study details on the page.SummaryDifference0.4%

- Check10 days agoChange DetectedA government funding notice was added to inform users about potential disruptions and where to check status updates. The site revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check17 days agoChange DetectedAdded a glossary toggle and a new revision reference (v3.4.0). Updated capitalization and wording for QC criteria labeling and the FEAR Act data line, and removed the older v3.3.4 reference.SummaryDifference0.2%

- Check31 days agoChange DetectedThe page shows Revision: v3.3.4 (replacing v3.3.3), indicating a minor update with no changes to study details.SummaryDifference0.1%

- Check53 days agoChange DetectedNew York is added as a participating location for the study (Montefiore Medical Center, The Bronx).SummaryDifference0.2%

- Check75 days agoChange DetectedFooter revision indicator updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.